✦ LIBER ✦

4517 POSTER Sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC)

✍ Scribed by George, D.J.; Michaelson, M.D.; Rosenberg, J.E.; Redman, B.G.; Hudes, G.R.; Bukowski, R.M.; Kim, S.T.; Chen, I.; Wilding, G.; Motzer, R.J.

Book ID: 123550200
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 67 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71148-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib in Patients With Metastatic Re

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

✍ Kibel, A.S.; Ornstein, D.K.; Finley, D.S. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 76 KB

4504 ORAL A phase II study of continuous

4504 ORAL A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) – final results

✍ Escudier, B.; Srinivas, S.; Roigas, J.; Gillessen, S.; Harmenberg, U.; De Mulder 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

4513 POSTER Phase 1/2 study of sunitinib

4513 POSTER Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)

✍ Redman, B.G.; Hudes, G.R.; Kondagunta, G.V.; Patel, P.H.; Kim, S.T.; Chen, I.; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

1141 POSTER Neutropenia and Thrombocytop

1141 POSTER Neutropenia and Thrombocytopenia During Treatment as Biomarkers of Sunitinib Efficacy in Patients With Metastatic Renal Cell Carcinoma (mRCC)

✍ F. Donskov; A. Cams; C.H. Barrios; B. Escudier; S. Li; J. Perkins; R.J. Motzer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

7143 POSTER Prognosis of Patients With M

7143 POSTER Prognosis of Patients With Metastatic Renal Cell Carcinoma (mRCC) With Primary Resistance to Sunitinib: Is There Any Active Treatment?

✍ Albiqes, L.; lacovelli, R.; Porta, C.; Houede, N.; Laguerre, B.; Procopio, G.; L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Sorafenib in patients with metastatic re

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

✍ Jorge A. Garcia; Thomas E. Hutson; Paul Elson; C. Lance Cowey; Timothy Gilligan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views